OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 90 citing articles:

Cytokine Storm in COVID-19: Immunopathogenesis and Therapy
Christian Zanza, Tatsiana Romenskaya, A Manetti, et al.
Medicina (2022) Vol. 58, Iss. 2, pp. 144-144
Open Access | Times Cited: 254

Small-Molecule Inhibitors of the Coronavirus Spike: ACE2 Protein–Protein Interaction as Blockers of Viral Attachment and Entry for SARS-CoV-2
Damir Bojadzic, Óscar Garnica, Jinshui Chen, et al.
ACS Infectious Diseases (2021) Vol. 7, Iss. 6, pp. 1519-1534
Open Access | Times Cited: 124

COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes
Daniele Focosi, Massimo Franchini, Liise-anne Pirofski, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 3
Open Access | Times Cited: 91

Integrin mediates cell entry of the SARS-CoV-2 virus independent of cellular receptor ACE2
Jianmin Liu, Fan Lü, Yinghua Chen, et al.
Journal of Biological Chemistry (2022) Vol. 298, Iss. 3, pp. 101710-101710
Open Access | Times Cited: 60

The oxygen dissociation curve of blood in COVID-19
Dieter Böning, Wolfgang M. Kuebler, Wilhelm Bloch
AJP Lung Cellular and Molecular Physiology (2021) Vol. 321, Iss. 2, pp. L349-L357
Open Access | Times Cited: 59

Biosorption of Methylene blue using clove leaves waste modified with sodium hydroxide
Heri Septya Kusuma, Uyiosa Osagie Aigbe, Kingsley Eghonghon Ukhurebor, et al.
Results in Chemistry (2023) Vol. 5, pp. 100778-100778
Open Access | Times Cited: 29

G-Quadruplexes in the Regulation of Viral Gene Expressions and Their Impacts on Controlling Infection
Andrew R. Zareie, Prerna Dabral, Subhash C. Verma
Pathogens (2024) Vol. 13, Iss. 1, pp. 60-60
Open Access | Times Cited: 8

Methylene Blue has a potent antiviral activity against SARS-CoV-2 and H1N1 influenza virus in the absence of UV-activation in vitro
Valeria Cagno, Chiara Medaglia, Andreas Cerny, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 39

Targeting protein-protein interaction interfaces in COVID-19 drug discovery
Chung‐ke Chang, Shanmeng Lin, Roshan Satange, et al.
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 2246-2255
Open Access | Times Cited: 38

Methylene Blue-Based Nano and Microparticles: Fabrication and Applications in Photodynamic Therapy
Dong‐Jin Lim
Polymers (2021) Vol. 13, Iss. 22, pp. 3955-3955
Open Access | Times Cited: 35

Colloidal Aggregators in Biochemical SARS-CoV-2 Repurposing Screens
Henry O’Donnell, Tia A. Tummino, Conner Bardine, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 23, pp. 17530-17539
Open Access | Times Cited: 33

Photodynamic disinfection of SARS-CoV-2 clinical samples using a methylene blue formulation
Catarina S. Lobo, Paulo Rodrigues‐Santos, Dina Pereira, et al.
Photochemical & Photobiological Sciences (2022) Vol. 21, Iss. 6, pp. 1101-1109
Open Access | Times Cited: 26

Identification of broad anti-coronavirus chemical agents for repurposing against SARS-CoV-2 and variants of concern
Luca Murer, Romain Volle, Vardan Andriasyan, et al.
Current Research in Virological Science (2022) Vol. 3, pp. 100019-100019
Open Access | Times Cited: 26

Repurposing methylene blue in the management of COVID-19: Mechanistic aspects and clinical investigations
Neha Dabholkar, Srividya Gorantla, Sunil Kumar Dubey, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 142, pp. 112023-112023
Open Access | Times Cited: 32

Methylene blue: a controversial diagnostic acid and medication?
Marek Bužga, Evžen Machytka, Eliška Dvořáčková, et al.
Toxicology Research (2022) Vol. 11, Iss. 5, pp. 711-717
Open Access | Times Cited: 22

Photodynamic therapy reduces cell viability, migration and triggers necroptosis in prostate tumor cells
Laura Calazans de Melo Gomes, Amanda Branquinho de Oliveira Cunha, Luiz Felipe Fernandes Peixoto, et al.
Photochemical & Photobiological Sciences (2023) Vol. 22, Iss. 6, pp. 1341-1356
Open Access | Times Cited: 13

Methylene blue in covid-19
G. Scigliano, Giuseppe Augusto Scigliano
Medical Hypotheses (2020) Vol. 146, pp. 110455-110455
Open Access | Times Cited: 28

Methylene Blue for Treatment of Hospitalized COVID-19 Patients: A Randomized, Controlled, Open-Label Clinical Trial, Phase 2
Daryoush Hamidi-Alamdari, Saied Hafizi-Lotfabadi, Ahmad Bagheri Moghaddam, et al.
Revista de investigaci�n Cl�nica (2021) Vol. 73, Iss. 3
Open Access | Times Cited: 25

Mutation informatics: SARS-CoV-2 receptor-binding domain of the spike protein
Saroj Verma, Vaishali M. Patil, Manish Gupta
Drug Discovery Today (2022) Vol. 27, Iss. 10, pp. 103312-103312
Open Access | Times Cited: 19

Enhancement of E. coli inactivation by photosensitized erythrosine-based solar disinfection under weakly acidic conditions
Yi Liu, Wenhua Dong, Shuyi Shen, et al.
Water Research (2022) Vol. 212, pp. 118125-118125
Closed Access | Times Cited: 17

A Novel Approach of Combining Methylene Blue Photodynamic Inactivation, Photobiomodulation and Oral Ingested Methylene Blue in COVID-19 Management: A Pilot Clinical Study with 12-Month Follow-Up
Juliette Hepburn, Susan Williams-Lockhart, René‐Jean Bensadoun, et al.
Antioxidants (2022) Vol. 11, Iss. 11, pp. 2211-2211
Open Access | Times Cited: 17

Establishment of a Yeast Two-Hybrid-Based High-Throughput Screening Model for Selection of SARS-CoV-2 Spike-ACE2 Interaction Inhibitors
Dongsheng Li, Baoqing You, Keyu Guo, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 678-678
Open Access

Page 1 - Next Page

Scroll to top